Boehringer Ingelheim Animal Health UK Limited is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines. These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly for all people. We are continually seeking out solutions that will bring all areas of the Site up to the same level of overall web accessibility.
Hot Keys provide short cuts to certain pages within the web Site. To use the access keys hold down the ‘Alt’ key and enter the ‘Hot key’ number. The following shortcut Hot keys are active on the Boehringer Ingelheim Animal Health UK Limited website:
Alternative and short descriptive texts are available for all multimedia and non-text content. A simplified version of the Site is also available, displaying a page with descriptive texts in the place of all images and videos. All videos and multimedia give a size indication, so that downloading time can be estimated. If software is required to view the videos, a plug in download link will be posted. An HTML substitute for Flash Player will also be provided for future videos. All videos will be presented with player software which enables the user to play, pause, stop forward and rewind the video. Live web casts will be archived after broadcasting to be available for a later viewing. No flashing content will be provided.
There is a strict separation of content and layout via the proper use of HTML and CSS (Cascading Style Sheet). Layout tables are avoided where possible.
We are focusing on structuring items, making it possible to scan through a document and giving air to long texts. This includes:
We try to offer a clear navigation structure that helps you to find the content you are looking for in an easy and quick way.
Links contain title attributes which describe content and make sense out of context.
The use of short sentences and paragraphs and multiple entry points to additional information sources e.g. via teaser elements and related content areas will make it easier to comprehend the content.
In the meantime, should you experience any difficulty in accessing the Boehringer Ingelheim Animal Health UK Limited website, please do not hesitate to email us AHpetvetmarketing.GB@boehringer-ingelheim.co.uk
Vetmedin® Chew 1.25 mg, 5 mg and 10 mg chewable tablets for dogs. Active substance: Pimobendan. Uses: For the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid valve regurgitation). (See also section 4.9 of the SPC). For the treatment of dilated cardiomyopathy in the preclinical stage (asymptomatic with an increase in left ventricular end-systolic and end-diastolic diameter) in Doberman Pinschers following echocardiographic diagnosis of cardiac disease (see sections 4.4 and 4.5 of the SPC). For the treatment of dogs with myxomatous mitral valve disease (MMVD) in the preclinical stage (asymptomatic with a systolic mitral murmur and evidence of increased heart size) to delay the onset of clinical symptoms of heart failure (see sections 4.4 and 4.5 of the SPC). UK: POM-V IE: POM. For information about side effects, precautions, warnings and contraindications please refer to the product packaging and package leaflet. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746959 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries).
Email: vetenquiries@boehringer-ingelheim.com. Vetmedin® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under licence. ©2022 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: June 2022. UI-CAN-0166-2021. Use Medicines Responsibly.